Sanara MedTech Inc. SMTI
NASDAQ
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 28.43M | 28.14M | 27.80M | 27.55M | 26.33M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 28.43M | 28.14M | 27.80M | 27.55M | 26.33M |
| Cost of Revenue | 2.10M | 1.98M | 1.92M | 1.87M | 1.87M |
| Gross Profit | 26.33M | 26.16M | 25.87M | 25.67M | 24.46M |
| SG&A Expenses | 24.25M | 22.60M | 21.88M | 20.08M | 19.88M |
| Depreciation & Amortization | 613.00K | 619.10K | 587.30K | 668.40K | 610.90K |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 27.69M | 26.36M | 25.15M | 24.65M | 23.39M |
| Operating Income | 736.00K | 1.78M | 2.65M | 2.89M | 2.94M |
| Income Before Tax | -1.29M | -411.10K | 397.70K | -1.11M | 834.50K |
| Income Tax Expenses | -- | -- | -- | -- | -- |
| Earnings from Continuing Operations | -1.29M | -411.10K | 397.70K | -1.11M | 834.50K |
| Earnings from Discontinued Operations | -124.20K | -41.70K | 60.90K | -502.80K | -31.25M |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -400.00 | -- | 400.00 | 200.00 | 1.00K |
| Net Income | -1.41M | -452.90K | 459.00K | -1.61M | -30.41M |
| EBIT | 736.00K | 1.78M | 2.65M | 2.89M | 2.94M |
| EBITDA | 1.35M | 2.40M | 3.23M | 3.56M | 3.55M |
| EPS Basic | -0.16 | -0.05 | 0.05 | -0.19 | -3.52 |
| Normalized Basic EPS | -0.10 | -0.03 | 0.03 | 0.05 | 0.06 |
| EPS Diluted | -0.16 | -0.05 | 0.05 | -0.19 | -3.40 |
| Normalized Diluted EPS | -0.10 | -0.03 | 0.03 | 0.05 | 0.06 |
| Average Basic Shares Outstanding | 8.78M | 8.66M | 8.71M | 8.47M | 8.65M |
| Average Diluted Shares Outstanding | 8.78M | 8.66M | 8.99M | 8.47M | 8.94M |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |